# Itron Inc. (ITRI) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Technology / Electronic Components & Instruments. Price $98.22, market value $4.3 billion.

## Valuation
- **P/E (trailing): 15.9×** (5-yr avg 23.7×, 3-yr avg 23.7×). Itron Inc. trades at 15.9× trailing earnings, well below its own five-year average of 23.7×: cheap by its own standards. The Technology median in the September 2026 study was 32.1×. Forward P/E is 14.2×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.56**. A PEG of 0.56 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.9×**. Each dollar of revenue is priced at 1.9×.
- **Price / book: 2.5×**. The shares trade at 2.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 11.7×**. Enterprise value is 11.7× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 8.5%** (5-yr avg 4.0%). Free cash flow equals 8.5% of the market value, above its five-year average of 4.0%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.3%**. The inverse of the P/E: 6.3% of the price is earned each year.

## Profitability
- **Gross margin: 40.7%**. Itron Inc. keeps 40.7% of revenue after the direct cost of what it sells.
- **Operating margin: 13.7%**. 13.7% of revenue is left after running the business.
- **Net margin: 12.7%**. 12.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 17.5%**. 17.5% on shareholders' equity is solid.
- **Return on invested capital: 12.9%**. Return on all capital, debt included, is 12.9%.
- **Return on assets: 7.5%**. Each dollar of assets produces 7.5% of profit.

## Growth
- **Revenue growth (1 yr): -3.0%** (3-yr 9.7%/yr, 5-yr 1.7%/yr). Revenue fell 3.0% over the last year, against 1.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 25.5%**. Earnings per share rose 25.5%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 331.9%/yr**. Free cash flow has compounded at 331.9% a year over three years.

## Financial health
- **Debt to equity: 0.73**. Debt is 0.73 times equity, moderate leverage.
- **Net debt / EBITDA: 0.6×**. It would take 0.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.80** (quick 1.80). Current assets cover the next year's liabilities 1.80 times.
- **Altman Z-score: 3.12**. A Z-score of 3.12 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Itron Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (9 analysts). 9 analysts cover Itron Inc.; the consensus is buy, with an average price target of $128.56 (+31% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -0.6%** (YTD 7.4%, 3-mo -1.2%). The shares are down 0.6% over twelve months including dividends.
- **From 52-week high: -9.2%** (26.3% above the low). Trading 9% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 71**. An RSI of 71 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.39** (volatility 44%). Beta of 1.39 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ITRI · Page: https://foliofundamentals.com/stocks/itri

Not investment advice.